Close Menu

A Palo Alto company could be poised to potentially change the existing laboratory testing model for consumers, the San Francisco Business Times reports. 

Theranos has been offering tests based on a pin prick's worth of blood in Walgreens in the Phoenix area and one in Palo Alto, California for routine analysis such as blood cholesterol levels and diabetes, without a physician's order. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.